1 completed. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
Follow Vulintus, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Efficacy of Opti-Speech for Speech Treatment Opti-Speech - Articulation Disorder, Dysarthria | Not applicable | Completed | Vulintus, Inc. | 37 | 2016-01-01 | 2018-12-31 |
Articulation Disorders (1) · Deafness (1) · Dysarthria (1)
United States (1)
Holle L Carey, MS (1) · Jennell Vick, PhD (1) · Thomas F Campbell, PhD (1)
R44DC013467 (1)